SMI 9'134 0.1%  Dow 17'627 -0.8%  Nikkei 19'035 -0.9%  Euro 1.0415 -0.3% 
SPI 9'137 0.0%  EStoxx50 3'711 0.4%  Gold 1'202 1.5%  Dollar 0.9682 -0.4% 
DAX 12'003 0.3%  FTSE100 6'814 0.6%  Öl 55.4 0.5%  Pfund 1.4328 -0.6% 

Biomarin Pharmaceutical Aktie [Valor: 729021 / ISIN: US09061G1013]

Analysen zu Biomarin Pharmaceutical Inc.

27.03.15 Biomarin Pharmaceutical Buy UBS AG
27.03.15 Biomarin Pharmaceutical Buy Deutsche Bank AG
19.12.14 Biomarin Pharmaceutical Outperform RBC Capital Markets
11.12.14 Biomarin Pharmaceutical Buy UBS AG
25.11.14 Biomarin Pharmaceutical Outperform RBC Capital Markets
24.10.14 Biomarin Pharmaceutical Outperform RBC Capital Markets
06.11.12 Biomarin Pharmaceutical outperform RBC Capital Markets
03.09.12 Biomarin Pharmaceutical outperform RBC Capital Markets
28.08.12 Biomarin Pharmaceutical hold Deutsche Bank Securities
23.07.12 Biomarin Pharmaceutical outperform RBC Capital Markets
22.06.12 Biomarin Pharmaceutical outperform RBC Capital Markets
01.06.12 Biomarin Pharmaceutical outperform RBC Capital Markets
17.02.12 Biomarin Pharmaceutical outperform RBC Capital Markets
13.02.12 Biomarin Pharmaceutical outperform RBC Capital Markets
12.12.11 Biomarin Pharmaceutical buy Citigroup Corp.
08.12.11 Biomarin Pharmaceutical buy Citigroup Corp.
07.12.11 Biomarin Pharmaceutical buy Jefferies & Company Inc.
29.09.11 Biomarin Pharmaceutical buy Deutsche Bank Securities
25.10.10 Biomarin Pharmaceutical neutral Wedbush Morgan Securities Inc.
17.08.10 Biomarin Pharmaceutical neutral Wedbush Morgan Securities Inc.
16.04.10 Biomarin Pharmaceutical kaufen Der Aktionär
29.10.09 Biomarin Pharmaceutical outperform Credit Suisse Group
22.10.09 Biomarin Pharmaceutical buy Citigroup Corp.
19.10.09 Biomarin Pharmaceutical hold ROTH Capital Partners, LLC
08.10.09 Biomarin Pharmaceutical buy Jefferies & Company Inc.
03.08.09 Biomarin Pharmaceutical neutral Wedbush Morgan Securities Inc.
31.07.09 Biomarin Pharmaceutical buy Jefferies & Company Inc.
27.07.09 Biomarin Pharmaceutical buy ROTH Capital Partners, LLC
31.03.09 Biomarin Pharmaceutical market weight Thomas Weisel Partners LLC
27.03.09 Biomarin Pharmaceutical neutral Piper Jaffray & Co.
12.03.09 Biomarin Pharmaceutical outperform Leerink Swann LLC
12.03.09 Biomarin Pharmaceutical buy FTN Midwest Securities Corp.
24.02.09 Biomarin Pharmaceutical buy ROTH Capital Partners, LLC
23.02.09 Biomarin Pharmaceutical buy Jefferies & Company Inc.
19.02.09 Biomarin Pharmaceutical neutral Credit Suisse Group
19.02.09 Biomarin Pharmaceutical market perform Wachovia Securities, LLC
19.02.09 Biomarin Pharmaceutical hold ROTH Capital Partners, LLC
19.02.09 Biomarin Pharmaceutical buy Brean Murray, Carret & Co., LLC
09.01.09 Biomarin Pharmaceutical buy Brean Murray, Carret & Co., LLC
15.12.08 Biomarin Pharmaceutical neutral Credit Suisse Group
26.11.08 Biomarin Pharmaceutical outperform Cowen and Company, LLC
24.11.08 Biomarin Pharmaceutical buy Citigroup Corp.
30.10.08 Biomarin Pharmaceutical neutral Credit Suisse Group
30.10.08 Biomarin Pharmaceutical buy UBS AG
29.10.08 Biomarin Pharmaceutical hold ROTH Capital Partners, LLC
12.09.08 Biomarin Pharmaceutical outperform William Blair
27.08.08 Biomarin Pharmaceutical outperform Cowen and Company, LLC
22.08.08 Biomarin Pharmaceutical hold ROTH Capital Partners, LLC
22.08.08 Biomarin Pharmaceutical market outperform Rodman & Renshaw, LLC
22.08.08 Biomarin Pharmaceutical outperform Cowen and Company, LLC
Seite: 1 | 2

Anmeldung notwendig

Benutzername (E-Mail):
Passwort:
 
Anmelden
 

Um diese Funktionalität nutzen zu können, müssen Sie sich anmelden.
Falls Sie noch kein Benutzerkonto bei finanzen.ch besitzen, können Sie sich hier kostenlos registrieren.

Eintrag hinzufügen

Aktuelle Aktienanalysen
15:28 Salzgitter Verkaufen Independent Research GmbH
15:27 Vestas Wind Systems A-S Conviction Buy List Goldman Sachs Group Inc.
15:07 Philips Electronics Conviction Buy List Goldman Sachs Group Inc.
14:57 Charter Communications Buy Canaccord Adams
14:52 NORMA Group Outperform Macquarie Research
14:47 Freshpet Buy Canaccord Adams
14:40 Cytosorbents Buy MLV Capital
14:32 Catamaran Neutral Mizuho
14:28 Nemetschek Hold Hauck & Aufhäuser Privatbankiers KGaA
14:26 QSC Sell Hauck & Aufhäuser Privatbankiers KGaA
14:22 Biotest vz buy Hauck & Aufhäuser Privatbankiers KGaA
14:19 HeidelbergCement kaufen Independent Research GmbH
14:17 Lloyds Banking Group Hold Jefferies & Company Inc.
14:16 Salzgitter Hold Jefferies & Company Inc.
14:07 Philips Electronics Neutral UBS AG
14:00 UniCredit overweight Morgan Stanley
14:00 Banco Bilbao Vizcaya Argentaria overweight Morgan Stanley
13:59 Banco Santander Central Hispano Equal-Weight Morgan Stanley
13:35 National Grid Neutral Citigroup Corp.
13:33 GDF SUEZ Neutral Citigroup Corp.
13:31 Enel Neutral Citigroup Corp.
13:31 EON Sell Citigroup Corp.
13:30 Dyax Outperform Oppenheimer & Co. Inc.
13:27 Altera Hold Argus Research Company
13:26 Achaogen Buy Needham & Company, LLC
13:24 Sypris Solutions Hold Needham & Company, LLC
13:21 Domtar Neutral D.A. Davidson & Co.
13:20 2U Outperform Oppenheimer & Co. Inc.
13:18 Sally Beauty Perform Oppenheimer & Co. Inc.
13:17 Alibaba Outperform Oppenheimer & Co. Inc.
13:15 zulil a Outperform Oppenheimer & Co. Inc.
13:13 Wayfai a Perform Oppenheimer & Co. Inc.
13:08 RWE Sell Citigroup Corp.
12:53 The Mosaic Buy Stifel, Nicolaus & Co., Inc.
12:51 Freshpet Buy Stifel, Nicolaus & Co., Inc.
12:48 Kinder Morgan Buy Stifel, Nicolaus & Co., Inc.
12:43 Dialog Semiconductor neutral Morgan Stanley
12:39 ElringKlinger Hold Oddo Seydler Bank AG
12:35 Dyax Outperform RBC Capital Markets
12:35 Münchener Rückversicherungs-Gesellschaft Halten Independent Research GmbH
12:34 UTI Worldwide Sector Perform RBC Capital Markets
12:31 QSC Halten Independent Research GmbH
12:24 Xylem Outperform Boenning & Scattergood
12:23 Salzgitter Verkaufen DZ-Bank AG
12:22 ITC Hold Wunderlich
12:15 Charter Communications Hold Wunderlich
11:58 Air Liquide buy Deutsche Bank AG
11:58 Commerzbank overweight Morgan Stanley
11:58 Yara International ASA Hold Deutsche Bank AG
11:57 UBS Group overweight Morgan Stanley